Ipamorelin

Growth Hormone SecretagogueResearch Use Only

Also known as: NNC 26-0161

Ipamorelin is a selective growth-hormone secretagogue and ghrelin-receptor agonist commonly referenced in research literature for stimulating growth-hormone release with relatively little effect on cortisol or prolactin. It is frequently studied as a comparatively selective member of the GHRP family. This entry is educational and research-use-only and is not medical advice.

Typical range (research)

Commonly referenced in literature around 200–300 mcg per administration, once to three times daily (research reference only)

Half-life

~2 hours

Route

Subcutaneous (research)

Common use

Studied as a selective growth-hormone secretagogue in growth-hormone axis research

Common vial sizes

5 mg · 10 mg

Storage

Lyophilized powder stored refrigerated or frozen away from light; reconstituted solution refrigerated (2–8 °C) and used within a few weeks

Stacking notes

Commonly paired with a GHRH analog such as CJC-1295 (with or without DAC) in research discussions

Reported side effects

Injection-site reactionTransient headache reported anecdotallyHead-rush or flushing reported anecdotally

Regulatory note: Not an approved therapeutic; sold for research purposes only

Calculate a dose →

Dose figures are ranges commonly referenced in research literature, not recommendations or medical advice. Not for human or veterinary use. Consult a licensed physician.